The global market for Metagenome-Assembled Genomes (MAGs) services is on a rapid growth trajectory, fueled by advancements in sequencing technologies, bioinformatics, and microbiome research. According to a report added to ResearchAndMarkets.com, the market is expected to expand from $1.38 billion in 2025 to $1.60 billion in 2026, with a compound annual growth rate (CAGR) of 15.7%.
Historically, the growth of this market has been driven by enhancements in next-generation sequencing technologies, the broader availability of high-throughput sequencing platforms, increased funding for environmental microbiology, and the continuous development of bioinformatics expertise and infrastructure. These advancements have enabled research organizations and biotechnology firms to analyze complex microbial communities with improved accuracy and efficiency.
The MAGs services market is projected to reach $2.89 billion by 2030, expanding at a CAGR of 15.9% from 2026. This growth is anticipated to be supported by an increasing demand for precision microbiome-based therapeutics, the adoption of artificial intelligence-driven genome reconstruction tools, and the broader application of microbial analysis in agriculture. Other factors contributing to growth include the expansion of cloud-based bioinformatics services and a heightened interest in exploring uncultured microbial diversity.
Key trends in the MAGs services market include the growing adoption of hybrid genome assembly methods and a rising demand for high-quality metagenome binning. Long-read sequencing is gaining traction as researchers aim to analyze complex microbiomes and reconstruct more complete microbial genomes. Service providers are expanding their functional and comparative genomics annotation capabilities and integrating customized, end-to-end bioinformatics pipelines into their service offerings.
The prevalence of infectious diseases is expected to bolster the demand for MAGs sequencing and bioinformatics services. Urbanization and increasing population density can enhance opportunities for pathogen transmission, necessitating advanced microbial surveillance and analysis. MAGs services enable researchers to reconstruct microbial genomes from clinical and environmental samples, aiding in pathogen identification, outbreak monitoring, microbial diversity analysis, and the investigation of antimicrobial resistance mechanisms.
In March 2024, the Centers for Disease Control and Prevention reported a rise in tuberculosis cases in the United States, from 8,320 in 2022 to 9,615 in 2023. This increase of 1,295 cases underscores the ongoing need for technologies that can enhance infectious disease research, microbial monitoring, and public health response capabilities.
Innovation remains a crucial competitive factor in the MAGs services industry. Service providers are investing in high-resolution long-read sequencing, optimized sample preparation, high-fidelity analysis, and robust bioinformatics workflows. These capabilities can enhance the accuracy and completeness of microbial genome reconstruction while reducing ambiguity in complex genome assemblies.
In April 2024, Clinical Microbiomics A/S launched advanced long-read 16S, ITS, 18S isolate, and metagenomics sequencing services. This offering combines optimized sample preparation, long-read sequencing, and bioinformatics pipelines to support detailed microbial identification and functional analysis. It is designed to help researchers investigate environmental, clinical, and gut microbiomes at higher resolution while supporting high-throughput studies. Potential applications include microbiome research, clinical diagnostics, and biotechnology development.
Market consolidation is also strengthening technical capabilities and broadening service coverage. In March 2024, Clinical Microbiomics A/S acquired DNASense ApS to integrate long-read DNA and RNA sequencing capabilities and expand microbiome services across human health, animal health, and environmental applications.
North America was the largest region in the MAGs services market in 2025, while Asia-Pacific is expected to record the fastest growth during the forecast period. The market encompasses regions such as Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Countries analyzed include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy, and Spain.
The report covers various market segments, including service types like genome assembly, genome annotation, data analysis, and custom bioinformatics. Technologies involved include next-generation sequencing, third-generation sequencing, cloud-based bioinformatics platforms, and AI and machine learning-based analytics. Applications span environmental microbiology, clinical diagnostics, agricultural research, biotechnology, and more.
Footnotes:
- The global MAGs services market is projected to grow from $1.38 billion in 2025 to $1.60 billion in 2026. Source.
- The market is expected to reach $2.89 billion by 2030, expanding at a CAGR of 15.9%. Source.
- In March 2024, the CDC reported an increase in tuberculosis cases in the U.S. Source.
Featured Image: Megapixl @ Natalimis
